VAERS Explorer
Back to explore

Report #2837331

Received Apr 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
ID
Recovered
Unknown
Vaccinated
Mar 26, 2025
Onset
Mar 26, 2025
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKY013350—
HIBVHIB (PEDVAXHIB)MERCK & CO. INC.UNKX022981OT

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

Caller reported PEDVAX HIB was administered after a temperature excursion. No other information provided. No PQC reported; This spontaneous report was received from an Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 26-MAR-2025, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (lot #X022981, expiration date: 21-May-2026) 0.5 mL, administered by Intramuscular route for prophylaxis. It was reported that the vaccine was administered after a temperature excursion (Product storage error). Temperature excursion was reported as 54.19 F for the time frame of 2 hours 45 minutes. No other information was provided.